What is cerebral venous sinus thrombosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cerebral Venous Sinus Thrombosis (CVST)

Cerebral venous sinus thrombosis (CVST) is a rare form of stroke (0.5-1% of all strokes) caused by blood clot formation in the brain's venous sinuses or cerebral veins, leading to impaired venous drainage and increased intracranial pressure. 1, 2

Clinical Presentation

  • Headache is the most common symptom, occurring in nearly 90% of patients, typically diffuse and progressively worsening over days to weeks 1
  • Seizures occur in approximately 40% of patients, which is significantly higher than in arterial stroke 1, 2
  • Focal neurological deficits, most commonly hemiparesis and aphasia, are present in many CVST patients 1
  • Papilledema and diplopia (sixth nerve palsy) due to increased intracranial pressure are common manifestations 1
  • Altered mental status, especially with deep venous system involvement, can occur without obvious focal neurological abnormalities 3, 2
  • Presentation is typically subacute with slower symptom progression (37% presenting acutely, 56% subacutely, and 7% chronically) 2

Patient Demographics and Risk Factors

  • CVST predominantly affects younger individuals, with 78% of cases occurring in patients under 50 years of age 2
  • Women are more frequently affected than men, particularly those taking oral contraceptives or who are pregnant/postpartum 2
  • Major risk factors include: 2
    • Prothrombotic conditions (inherited thrombophilias such as protein C deficiency, protein S deficiency, antithrombin III deficiency, factor V Leiden)
    • Oral contraceptive use
    • Pregnancy and puerperium
    • Malignancy
    • Inflammatory conditions
    • Dehydration 1

Diagnostic Approach

Laboratory Studies

  • D-dimer may be elevated but a normal level doesn't exclude CVST, especially with limited clot burden 1
  • Routine blood studies (CBC, chemistry, PT, aPTT) should be performed 1

Imaging

  • Non-contrast CT has limited sensitivity (abnormal in only 30% of cases) 3, 2
    • May show hyperdensity of cortical vein or dural sinus in acute phase 3
    • "Empty delta" sign may appear on contrast-enhanced CT 3, 2
  • MRI with MR venography is more sensitive and is the preferred diagnostic modality 3, 1, 2
    • Shows both venous occlusion and parenchymal changes
    • Findings include absence of flow void with altered signal intensity in dural sinus 3
    • Venous infarcts are often hemorrhagic and located near venous sinuses 2

Comparison of CT vs MRI for CVST Diagnosis

CT+CTV MRI+MRV
Good visualization of major venous sinuses Better visualization of superficial and deep venous systems
Quick (5-10 min) and readily available Better definition of brain parenchyma
Fewer motion artifacts Early detection of ischemic changes
Can be used in patients with pacemakers or claustrophobia No radiation exposure
Limited in detecting cortical and deep venous thrombosis Better detection of cortical and deep venous thrombosis [3]

Common Diagnostic Pitfalls

  • Delayed diagnosis is common due to variable presentation and slower progression (median 7 days from symptom onset to diagnosis) 2
  • May be misdiagnosed as idiopathic intracranial hypertension, especially when presenting with isolated headache and papilledema 2
  • Normal non-contrast CT does not exclude CVST; further imaging with CTV or MRV should be pursued when clinical suspicion is high 2
  • Isolated mental status changes without focal neurological deficits (more common in elderly and with deep venous system involvement) can lead to missed diagnosis 3
  • CVST can mimic arterial stroke but typically has more subacute presentation and may cross arterial boundaries 2

Treatment

  • Anticoagulation is the mainstay of treatment, even in the presence of hemorrhagic lesions 2
  • Intravenous heparin or subcutaneous low molecular weight heparin is recommended initially 3
  • For patients with severe mass effect or intracranial hemorrhage with neurological deterioration: 3
    • Endovascular therapy may be considered
    • Decompressive hemicraniectomy may be life-saving in severe cases

Prognosis

  • Early diagnosis and treatment significantly improve outcomes and reduce morbidity and mortality 4
  • Favorable outcomes are reported in patients who receive prompt diagnosis and appropriate treatment 4

References

Guideline

Cerebral Venous Sinus Thrombosis (CVST) Clinical Presentation and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cerebral Venous Thrombosis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.